Your browser doesn't support javascript.
loading
Population pharmacokinetics and exposure-response of osimertinib in patients with non-small cell lung cancer.
Brown, Kathryn; Comisar, Craig; Witjes, Han; Maringwa, John; de Greef, Rik; Vishwanathan, Karthick; Cantarini, Mireille; Cox, Eugène.
Afiliación
  • Brown K; UCB, Slough, UK.
  • Comisar C; Quantitative Solutions, a Certara company, Breda, The Netherlands.
  • Witjes H; Quantitative Solutions, a Certara company, Breda, The Netherlands.
  • Maringwa J; Quantitative Solutions, a Certara company, Breda, The Netherlands.
  • de Greef R; Quantitative Solutions, a Certara company, Breda, The Netherlands.
  • Vishwanathan K; AstraZeneca, Waltham, USA.
  • Cantarini M; AstraZeneca, Alderley Park, UK.
  • Cox E; Quantitative Solutions, a Certara company, Breda, The Netherlands.
Br J Clin Pharmacol ; 83(6): 1216-1226, 2017 06.
Article en En | MEDLINE | ID: mdl-28009438
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Piperazinas / Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Clin Pharmacol Año: 2017 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Piperazinas / Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Clin Pharmacol Año: 2017 Tipo del documento: Article País de afiliación: Reino Unido